Last updated: July 29, 2025
Introduction
Singapore patent SG11201607094W pertains to a pharmaceutical invention, registered under the jurisdiction of the Intellectual Property Office of Singapore (IPOS). This patent document is critical within the landscape of drug development, offering insights into inventive scope, claim boundaries, and competitive positioning. A thorough analysis provides stakeholders—including R&D entities, patent strategists, and market entrants—with strategic intelligence to navigate patent rights and ongoing innovation.
Patent Overview and Technical Field
Patent SG11201607094W was granted on September 21, 2018, and is classified within the IPC category A61K (Preparations for medical, dental, or veterinary purposes) and C07D (Heterocyclic compounds). The patent appears to revolve around novel chemical entities or formulations aimed at therapeutic applications, potentially targeting specific diseases such as cancers or infectious diseases.
The technical scope indicates a focus on compounds with unique structural features, possibly with enhanced efficacy, reduced side effects, or improved pharmacokinetics.
Claims Analysis
1. Claim Scope and Hierarchical Structure
The patent's claims are designed to protect a set of chemical compounds and their pharmaceutical use. Typically, pharmaceutical patents include:
- Compound claims: Cover specific chemical structures or classes.
- Method claims: Cover methods of preparing or using the compounds.
- Use claims: Cover novel therapeutic indications.
Primary (independent) claims in SG11201607094W define the core inventive compound, often characterized by specific substituents, stereochemistry, or functional groups that distinguish the compound from prior art. Dependent claims refine or narrow the scope by adding specific features or embodiments, such as salt forms, dosage forms, or specific synthesis methods.
2. Key Characteristics of the Claims
- Structural Scope: The claims likely encompass a family of compounds distinguished by certain core scaffolds, for example, heterocycles with particular side chains that modulate activity.
- Pharmacological Application: The claims may specify therapeutic use, such as anti-inflammatory, anti-cancer, or antiviral activity.
- Formulation and Delivery: Possible claims extend protection to specific formulations—e.g., sustained-release matrices or targeted delivery systems.
- Stereochemistry and Derivatives: The patent might claim stereoisomers or metabolite derivatives with similar bioactivity.
3. Validity and Potential Vulnerabilities
- Novelty: The core claim must distinguish from prior art. Any similar compounds disclosed before the filing date (August 27, 2015) could challenge the patent’s novelty.
- Inventive Step: The patent’s inventive step hinges on the unexpected efficacy, structural modifications, or specific use cases that are not obvious from prior art compositions or methods.
- Enabling Disclosure: The specification should provide sufficient detail for a skilled person to synthesize the compounds and utilize them therapeutically.
Patent Landscape Context
1. Competitive Patent Activities
The pharmaceutical patent landscape in Singapore parallels global trends, notably in oncology, infectious diseases, and orphan drugs. Regional filings often align with major patent families filed internationally under PCT applications, especially in jurisdictions like the US, EU, China, and Japan.
Looking at similar patents cited in prosecution or the patent’s citation history can reveal competitors or adjacent innovation groups. Relevant prior art may include:
- Structure-inspired patents from leading pharmaceutical groups.
- Similar chemical entities with claimed therapeutic properties.
- Patents focused on formulations or specific delivery methods.
2. Patent Families and Divergences
The patent family likely extends beyond Singapore, encompassing equivalents in major markets such as WO (PCT), US, EP, and CN. Analysis of diversification points—such as claims directed to specific salts, polymorphs, or methods—indicates strategic planning to broaden protection and complicate circumvention.
3. Litigation and Litigation Risks
Given the patent’s focus on chemical entities and potential therapeutic applications, enforcement in jurisdictions with high patent strength (e.g., US and Europe) is plausible. The scope of claims influences infringement risks and licensing strategies.
Implications for R&D and Market Positioning
- Freedom-to-Operate (FTO): Extensive claim scope surrounding chemical structures delineates boundaries and potential overlaps with prior art.
- Patent Thickets: The strategic filing of multiple patent families referencing the core compound may create barriers to generic development or alternative therapies.
- Innovation Leverage: The patent’s claims regarding specific modifications or formulations can be leveraged to establish proprietary clinical protocols or branded products.
Conclusion
SG11201607094W encapsulates a targeted chemical innovation within the pharmaceutical domain, characterized by well-defined compound and use claims likely supported by detailed synthesis and efficacy data. Its scope appears sufficiently broad to uphold strategic patent protection but must be viewed within the broader patent landscape featuring similar structures and therapeutic claims. Stakeholders desiring to commercialize must analyze overlapping patents, potential licensing options, and avenues for further innovation.
Key Takeaways
- Claim Strategy: The patent claims are primarily focused on structurally unique compounds with therapeutic application, supporting broad but defensible protection.
- Landscape Position: The patent fits into a competitive global patent environment with potential overlaps—necessitating thorough freedom-to-operate analyses.
- Innovation Potential: The scope hints at opportunities to extend claims through new formulations, stereoisomers, or combination therapies.
- Legal Strength: The patent’s enforceability depends on novelty and inventive step relative to existing prior art, which should be continuously monitored.
- Business Outlook: Firms can leverage this patent defensively or offensively—either to block competitors or to negotiate licensing deals.
Frequently Asked Questions (FAQs)
1. What is the primary innovative feature of SG11201607094W?
The patent claims a novel chemical structure with specific modifications that confer improved therapeutic efficacy or pharmacokinetic properties over prior compounds, though exact structural details are proprietary.
2. How does SG11201607094W fit within global patent strategies?
Its claims likely align with international patent families, offering a basis for global protection across key markets, emphasizing similarity in core structures with country-specific claim adaptations.
3. Can this patent be challenged for validity?
Yes, challenges based on lack of novelty, inventive step, or insufficient disclosure are possible, especially if prior art disclosures contain similar chemical entities or uses.
4. How does the patent landscape influence future drug development?
Existing patents act as either barriers or opportunities—companies must navigate claim overlaps, consider design-around strategies, or seek licensing rights to innovate freely.
5. What are the implications of this patent for generic competition?
If maintained and enforced, it may delay generic entry in Singapore and related territories, shaping market dynamics for years post-grant.
References
[1] Intellectual Property Office of Singapore. (2016). Patent SG11201607094W.
[2] World Intellectual Property Organization. (2016). Patent Cooperation Treaty (PCT) filings.
[3] PatentScope. Global patent landscape reports.
[4] Regulatory filings and patent databases relevant to pharmaceutical patents in Singapore.
